StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) stock

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.61+0.02 (+3.06%)

Close on Nov 17, 2026Market cap $3.44MP/E –Yield –

Imunon price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Imunon's price to sales ratio was 127.0× on Jan 31, 2024, against 292.6× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 2024127.0×−39.1
2023Dec 29, 2023166.2×−83.8
2022Dec 30, 2022250.0×−160.0
2020Oct 30, 2020410.0×–

More Imunon figures

See a number that looks wrong?